---
title: "Golden Throat posts FY revenue RMB 943.3 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280818885.md"
description: "Golden Throat posts FY revenue RMB 943.3 million"
datetime: "2026-03-27T15:35:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280818885.md)
  - [en](https://longbridge.com/en/news/280818885.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280818885.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280818885.md) | [繁體中文](https://longbridge.com/zh-HK/news/280818885.md)


# Golden Throat posts FY revenue RMB 943.3 million

Golden Throat posts FY revenue RMB 943.3 million

### Related Stocks

- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/en/quote/512290.CN.md)
- [GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.CN)](https://longbridge.com/en/quote/513120.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/en/quote/516930.CN.md)
- [GOLDEN THROAT (06896.HK)](https://longbridge.com/en/quote/06896.HK.md)
- [Bosera Hang Seng Health Care ETF(QDII) (513060.CN)](https://longbridge.com/en/quote/513060.CN.md)
- [China Universal 800 Health Care ETF (159929.CN)](https://longbridge.com/en/quote/159929.CN.md)
- [Penghua CSI HK Connect Health Care Composite ETF (513700.CN)](https://longbridge.com/en/quote/513700.CN.md)
- [ChinaAMC Hang Seng Biotechnology Technology ETF(QDII) (159892.CN)](https://longbridge.com/en/quote/159892.CN.md)
- [Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF (159506.CN)](https://longbridge.com/en/quote/159506.CN.md)
- [Guotai SSE STAR Brand Name Drug ETF (589720.CN)](https://longbridge.com/en/quote/589720.CN.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/en/quote/512010.CN.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/en/quote/510660.CN.md)
- [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/en/quote/159316.CN.md)
- [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/en/quote/520880.CN.md)
- [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/en/quote/520690.CN.md)
- [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/en/quote/159992.CN.md)
- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/en/quote/588130.CN.md)

## Related News & Research

- [Xinhua Pharma Becomes Marketing Authorization Holder of Dental Drug After Regulatory Nod](https://longbridge.com/en/news/281343251.md)
- [Golden Throat Profit Falls Over 20% in 2025 but Dividend Maintained](https://longbridge.com/en/news/280842508.md)
- [3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady](https://longbridge.com/en/news/281054154.md)
- [Akeso FY revenue RMB 3,056.3 million](https://longbridge.com/en/news/280664190.md)
- [ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma](https://longbridge.com/en/news/281068292.md)